1.5 mg semaglutide to tirzepatide

1.5 mg semaglutide to tirzepatide Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Switching between weight-loss medications -

Name: 1.5 mg semaglutide to tirzepatide Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Switching between weight-loss medications -
Brand: actil.am
SKU: 13915012460
Price: 21.01 USD
Availability: InStock
Rating: 4.749700000000001 (26 reviews)

SKU: 13915012460

4.7

USD21.01 USD50.01

Pay in 4 interest-free payments of $5.25 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 1 - Sep 6

Description

Dietary Drift As side effects diminish over the first few months, eating patterns may gradually drift back toward pre-treatment habits

Tirzepatide (Mounjaro and Zepbound), semaglutide-based medications such as Wegovy, and other GLP-1based treatments require medical evaluation to determine eligibility, appropriate dosing, and safety

If you notice any cloudiness, particles, or a change in color, do not use it